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Though we are already indebted to Dr M.K. Agar- 
wal, the editor of this book, for a previous book 
on the same subject with the title ‘Anti-Hormo- 
nes’ , published by Elsevier Biomedical Press 
(Amsterdam, New York) in 1979 (DM 207.00) we 
have now been blessed with another rendition of 
the same. For example, of the 39 articles in the new 
book, 12 are by the same groups of authors and 
deal with similar or closely related subjects. Of 
these, at least the article of Vecsei et al. is nearly 
the same including the same data already published 
in 1979. The same applies to the article of Dry and 
Pradalier, to give only an example. This of course 
raises the question how much worthwhile new in- 
formation is presented in the new book which 
would justify an expenditure of about $ 75. But 
quite aside from that, it is doubtful whether this 
compilation of multiauthored reports under the 
heading ‘Hormone Antagonists’ deserves to be 
called a book. The least one might reasonably ex- 
pect from an editor of a book representing the ef- 
forts of so many authors is a thoughtful and con- 
siderate effort to avoid overlap and redundancy. 
More importantly, the editor is responsible to keep 
focus on the main theme: He must give the whole 
endeavour intellectual cohesion and prevent a lux- 
urious overgrowth of side issues only distantly 
related to the main theme. I am afraid that the 
editor has not taken his responsibilities eriously 
enough because the fruits of his labor are a com- 
pilation of separate research reports more like a 
symposium report than a book. There is little 
which points to the guiding hand of an experienced 
editor. The largest section (section 1, 429 pages) 
deals with steroid hormone antagonists. It contains 
24 separate articles among them two contributions 
by the editor himself. The topic is introduced with 
a treatment of structural requirements of steroid 
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agonists and antagonists for receptor binding and 
activity (2 chapters). This is followed by a discus- 
sion of the consequences of passive and active im- 
munization against testosterone, estrogens, pro- 
gesterone and mineralo- and glucocorticoids. The 
role of low-M, endogenous inhibitors which in- 
terfere with steroid hormone-receptor interactions 
is also considered, although the chemical nature of 
these inhibitors remains unknown and a matter of 
speculation. Among the estrogen antagonists non- 
steroidal anti-estrogens have played an important 
role in the treatment of breast cancer in recent 
years. Tamoxifen and related compounds are 
derived from triphenylethylene like some of the 
most potent longlasting non-steroidal estrogens. 
The effects of this type of anti-estrogens i  treated 
by different groups in no less than 7 separate 
chapters with a total of 124 pages. But nobody 
cared to summarize the results, point out unresolv- 
ed questions and perhaps discrepancies in results 
and interpretations and fmally give an outlook for 
the future. Anti-progestational agents, anti- 
androgens and anti-mineralcorticoids are treated 
next. As anti-androgens ubstances were catalog- 
ued which prevent or reduce the physiological ac- 
tions of androgens, whereas anti-mineralocorti- 
coids are substances which inhibit the action of 
aldosterone and other mineralcorticoids at dif- 
ferent target levels. 
Section 2 (224 pages) deals with peptide hor- 
mone antagonists. Again the topic is introduced by 
a valuable chapter written by Hruby and Mosberg 
on structural considerations for the design of pep- 
tide hormone analogs. The next chapter deals with 
clinically important anti-hypertensive inhibitors of 
the renin-angiotensin system and the angiotensin 
converting enzyme. Studies on anti-prolactin 
receptor and anti-growth hormone receptor an- 
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tibodies and comparisons with effects of anti- 
prolactin and anti-growth hormone antibodies are 
reported next. This is followed by reviews on the 
clinical use of prolactin lowering drugs and an- 
tagonists of gastrointestinal peptides which act at 
the receptor level in pancreatic acinar cells. One of 
the more interesting subjects deals with non- 
degradable agonists and antagonists of gonado- 
tropin releasing hormone. The obvious interest lies 
in anti-fertility action of gonadotropin releasing 
hormone analogs. These analogs are ovulation in- 
hibitors. A survey of substances available today 
which inhibit the action of hypothalamic peptides 
and dopamine on the anterior pituitary is included. 
Two chapters are devoted to the action of analogs 
of luteinizing hormone releasing peptides and the 
anti-reproductive action of such analogs which are 
anti-gonadotropic, anti-steroidogenic and anti- 
steroidal agents. 
The final section 3 (62 pages) is a hotchpotch 
containing among others a rather outdated chapter 
on hormonal inhibition of adenylate cyclase (hor- 
mones which inhibit adenylate cyclase are certainly 
not ‘anti-hormones’), a chapter on endorphin anti- 
hormones and an article on anti-histamines. This is 
topped by an excellent paper on X-ray crystallo- 
graphic studies of thyroid hormone by Colin C.F. 
Blake of the Oxford group. The concluding 
chapter is a cursive, speculative essay, only ques- 
tionable related to the theme of the book; ‘anti- 
pheromones’? 
There is no doubt that this compilation of widely 
divergent reports contains important information 
both for the pharmaceutical chemist and for the 
clinician as well. However, taken as a whole, the 
book suffers from lack of careful editing. Occa- 
sionally, a chapter is written badly and abounds in 
typing errors. The crucial question is, however: 
who needs this book? The expert certainly has ac- 
cess to original papers and to recent more detailled 
and up-to-date symposia reports. This reviewer at 
least could not be persuaded by the argument 
stated in the introduction that this book ‘will re- 
main a major reference source to advanced 
graduate students, research scientists and clinicians 
with a flair for fundamentals’. In order to fulfill 
this promise the book would have had to be much 
better organized with a stronger basis of fun- 
damental concepts on which to build and to add 
applied and clinically related subjects. Since, 
however, this expectation was not realized, I can 
not recommend the book as a whole. If one could 
purchase, however, reprints of one or the other 
report or section, the compilation of this hetero- 
genous information would have served its purpose. 
This would only necessitate purchase of a master 
copy by a central library and the willingness of the 
publishers to sell separata of parts of the book at 
a reasonable price. One might consider this possi- 
bility for the future when an editor again solicits 
contributions from workers in such a vast and 
diversified field which is, however, of great clinical 
and pharmaceutical interest. After all, financial 
resources are becoming scarce and the supply of 
specialized monographs is increasing exponen- 
tially. 
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Anion transport has become an area of extensive 
research and expanding knowledge so the present 
collection of articles is timely. Inevitably for a 
multiauthor work based on a symposium there are 
major differences in style and approach and some 
contributions are much more detailed than others. 
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